Saffron, A Curry Spice Can Prevent Blindness
According to a new study trial, saffron, a spice used in curries and which gives the curry its yellow colour, when given to volunteers for three months in the form of pills, brought about a significant improvement in their vision.
This has led to experts in Australia and Italy claiming the aromatic herb could hold the key to loss of eyesight in the elderly.
As well, the study’s findings indicate, the spice also protects the eyes from any damage caused by bright sunlight.
Study lead Prof. Silvia Bisti from the University of Sydney found patients’ vision to improve after taking the saffron pill for a recommended period of time.
When tested with traditional eye charts, many could read one or two lines smaller than they could before, whilst others were able to read newspapers and books again.
Similar tests carried out in Italy showed patients to experience vision improvement while taking the saffron pill, though the effects quickly disappeared after they stopped taking it.
Prof. Bisti first studied the effects of saffron at L’Aquila, a widely-grown local crop in Italy’s mountainous Abruzzi region, where it is a prized ingredient in the cooking of risotto, including being a traditional medicine used for treating cancerous tumours and depression.
Well-known as an antioxidant, Prof. Bisti believes saffron affects genes responsible for regulating the fatty acid content of the cell membrane, thus making the vision cells ‘tougher and more resilient’.
As well, the herb has properties that encourage oxygen flow, including preventing cell death.
A saffron diet in previous animals studies have shown it to protect the eye from the damaging effects of bright light.
Researchers have begun a year long trial to find out how saffron works, including its ability to treat genetic eye diseases like retinitis pigmentosa that caused lifelong blindness in young people.
- Login or register to post comments
Print
Email to friend
Related Articles
- Gene Therapy Improves Eye Sight
- Myanmar bomb victim was former Buddhist monk, claims state media
- Study: No Vision Loss Due to Erectile Dysfunction Drugs
- Aboriginal Blindness Preventable
- Turmeric And Pepper, Potential Breast Cancer Treatment
- Eye Gene Therapy Effective In The Young
- Fish Oil Helps Fight Psychosis
- Risk of Age-Related Vision Loss Decreases With Vitamin B, Folic Acid
While, many stories have been written about the many aspects of health-care reform, there are few on how the Americans have reacted and responded...
According to data from a government-sponsored study, adding a triglyceride-lowering drug to cholesterol-fighting statins i. e Tricor, Abbott...
Abbott Laboratories hopes to win the US Food and Drug Administration’s (FDA) approval to launch its new device – MitraClip that has been designed...
International trials of Novartis AG’s blood pressure pill Diovan and diabetes drug Starlix show, which they neither prevent heart attacks, strokes...
A British fertility clinic is holding a raffle this week, with first prize a human egg by way or promoting its ‘baby profiling’ service, it...
Alarmed by the unjustified use of potentially cancer-causing CT scans, the Medicare watchdog and senior radiologists have been prompted to call on...
Increasingly, knee replacements are becoming one of the most common surgeries in America, as painful arthritis wears out the original knee which...
While, the elderly with failing memories often risk getting lost even on familiar streets, a study of Alzheimer’s patients suggests the risk is...
President Barack Obama’s healthcare bill has rallied support from Support from the Catholic Health Association, a group representing Catholic...
The debate over prostate specific antigen (PSA), the most commonly used prostate cancer screening procedure continues to grow, ever since its...
Dealing another blow to parents blaming vaccines for their children’s illness, a special U. S. court ruled Friday, vaccines containing thimerosal...
The US Food and Drug Administration (FDA) said Friday, a boxed warning will be added to Plavix, an $8-billion-a-year anti-clotting drug sold by...












